Eisbach Bio Secures CPRIT Grant to Advance Novel Cancer Therapeutic
MARTINSRIED, Germany, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Eisbach Bio GmbH, a pioneering precision oncology company, is pleased to announce the receipt of a Texas Therapeutics Company Award from the Cancer Prevention and Research Institute of Texas (CPRIT). …